ERBB2 and breast carcinoma: In this study, we demonstrate that ERBB2 promotes autophagy by upregulating ATG12 as well as other autophagy-related (ATG) proteins including ULK1, FIP200, ATG5, and ATG7, leading to breast cancer treatment resistance and worse outcome to patients with ERBB2-positive breast cancer (Figure 9).